Scilex Holding Company Insider Trading

SCLX

⊜ Compare

Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in Dec 2024.

Net open-market

0 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

0 / 0

executives and directors

Last open-market buy

Dec 2024

Dec 18, 2024

Get an email when SCLX's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Dec 26, 2025 – Dec 30, 2025	Scilex Holding Co Large holder	SoldNo plan 3 parts	20,657,300	$0.62 average	$12.8M	7.8%	Form 4
Dec 18, 2024	Jaisim Shah See Remarks	Bought	30,000	$0.46	14K	11%	Form 4

Dec 26, 2025 – Dec 30, 2025No plan
Scilex Holding Co
Large holder · sold 20,657,300 at avg $0.62
$12.8M
7.8% of stake
Dec 18, 2024
Jaisim Shah
See Remarks · bought 30,000 at $0.46
14K
11% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch SCLX, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with SCLX

CompareIntrinsic value

GLUEMonte Rosa Therapeutics, Inc.

$10.82+3.94%10

VYGRVoyager Therapeutics Inc.

$1.87+2.19%10

SGMOSangamo Therapeutics Inc.

$0.12-0.20%10

CCCCC4 Therapeutics Inc.

$3.12-2.80%33

MGXMetagenomi, Inc.

$0.79+3.95%10

ACLXArcellx, Inc.

No recent price10

LENZLENZ Therapeutics, Inc.

$3.46-1.14%10

PTHSPelthos Therapeutics Inc.

$10.15-5.84%0

Spot a number that looks wrong? Check it in SCLX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing SCLX

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.